Список литературы

1. Международная классификация болезней 10 пересмотра (МКБ-10). http://mkb-10.com/index.php?pid=4048.

2. Брюн Е.А., Бузик О.Ж., Кутушев О.Т., Лыков В.И. Медицинская помощь в отказе от курения. Методические рекомендации Департамента здравоохранения г. Москвы N 44, 2012: 22 с.

3. Надеждин А.В., Тетенова Е.Ю. Зависимость от никотина: диагностика и лечение. Медицина, 2016; N 3: с. 164 - 189.

4. Benowitz NL. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clinical Pharmacology and Therapeutics 2008; 83(4): 531 - 41.

5. Чучалин А.Г., Сахарова Г.М. Болезни легких курящего человека. В кн.: Чучалин А.Г. (ред.) Хронические обструктивные болезни легких. М.: ЗАО "Изд-во БИНОМ"; 1998: 338 - 365.

6. Антонов Н.С., Сахарова Г.М. Табакокурение - фактор риска бронхолегочных заболеваний. В кн.: Респираторная медицина. Под ред. А.Г. Чучалина. М.: Литтерра, 2017; Том 1: с. 543 - 550.

7. Сахарова Г.М., Антонов Н.С., Салагай С.С. Глобальный опрос взрослого населения о потреблении табака в Российской Федерации: GATS 2009 и GATS 2016. Наркология, 2017; том 16, N 7: 8 - 12.

8. Чучалин А.Г., Сахарова Г.М., Антонов Н.С., Зайцева О.Ю., Новиков К.Ю. Комплексное лечение табачной зависимости и профилактика хронической обструктивной болезни легких, вызванной курением табака. Методические рекомендации Министерства здравоохранения Российской Федерации N 2002/154, 2003: 46 с.

9. Брюн Е.А., Бузик О.Ж., Кутушев О.Т., Лыков В.И. Профилактика и лечение табачной зависимости. Методические рекомендации Департамента здравоохранения г. Москвы N 29, части 1 и 2, 2016: 60 с.

10. Tonnesen P., Carrozzi L., Fagerstrom K.O., Gratziou C., Jimenez-Ruiz C., Nardini S., Viegi G., Lazzaro C., Campell I.A., Dagli E., West R. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J, 2007; 29: 390 - 417.

11. Антонов Н.С., Сахарова Г.М. Хроническая обструктивная болезнь легких у курящих: ранняя стадия болезни. Терапевтический архив, 2009; N 3: с. 82 - 84.

12. Bize R, Burnand B., Mueller Y., M., Camain J-Y, Cornuz J. Biomedical risk assessment as an aid for smoking cessation (Review). The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. http://www.thecochranelibrary.com, 2012: 43 p.

13. Lewis KF. Smoking cessation. Oxford University Press, 2012; 152 p.

14. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. U.S. Department of Health and Human Services Public Health Service, 2008; 276 p. https://www.healthquality.va.gov/tuc/phs_2008_quickguide.pdf

15. Jimenz-Ruiz C.A., Riesco Miranda J.A., Altet Gomez N. et al. Treatment of smoking in smokers with chronic obstructive pulmonary disease. Arch Bronconeumol, 2013; 49 (8): 354 - 363.

16. Background and Recommendations of The New Zealand Guidelines for Helping People to Stop Smoking. Ministry of Health NZ. 2014; 38 p. www.health.govt.nz

17. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation (Review). Cochrane Database of Systematic Reviews 2013, Issue 5, http://www.cochranelibrary.com; 75 p.

18. Lai DTC, Cahill K, Qin Y, Tang JL. Motivational interviewing for smoking cessation (Review). The Cochrane Library 2011, Issue 10, http://www.thecochranelibrary.com; 40 p.

19. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation (Review). Cochrane Database of Systematic Reviews 2016, Issue 3, http://www.cochranelibrary.com: 120 p.

20. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T. Nicotine replacement therapy for smoking cessation (Review). Cochrane Database of Systematic Reviews 2012, Issue 11, http://www.cochranelibrary.com: 267 p.

21. Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation (Review). Cochrane Database of Systematic Reviews 2016, Issue 5. http://www.cochranelibrary.com: 211 p.

22. Hughes JR, Stead LF, Lancaster T. Anxiolytics for smoking cessation (Review). He Cochrane Library, 2011, Issue 8, http://www.cochranelibrary.com: 23 p.

23. Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation (Review). Cochrane Database of Systematic Reviews 2014, Issue 1, www.cochranelibrary.com: 177 p.

24. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis (Review). Cochrane Database of Systematic Reviews 2013, Issue 5. http://www.cochranelibrary.com: 52 p.

25. Брюн Е.А., Кутушев О.Т., Харенко В.Н., Михайлова В.А. Роль и место иглорефлексотерапии в лечении табачной зависимости. Методические рекомендации Департамента здравоохранения г. Москвы N 49, 2008: 15 с.

26. White AR, Rampes H, Liu JP, Stead LF, Campbell J. Acupuncture and related interventions for smoking cessation (Review). The Cochrane Library, 2011, Issue 5, http://www.cochranelibrary.com: 71 p.

27. Cahill K, Ussher MH. Cannabinoid type 1 receptor antagonists for smoking cessation (Review). The Cochrane Library, 2012, Issue 7, http://www.cochranelibrary.com: 27 p.

28. Barnes J, Dong CY, McRobbie H, Walker N, Mehta M, Stead LF. Hypnotherapy for smoking cessation (Review). The Cochrane Library, 2010, Issue 10, http://www.cochranelibrary.com: 41 p.

29. Lancaster T, Stead LF. Mecamylamine (a nicotine antagonist) for smoking cessation (Review). The Cochrane Library, 2011, Issue 8, http://www.cochranelibrary.com: 14 p.

30. Stead LF, Lancaster T. Nicobrevin for smoking cessation (Review). The Cochrane Library, 2013, Issue 2, http://www.cochranelibrary.com: 9 p.

31. Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation (Review). Cochrane Database of Systematic Reviews 2016, Issue 9. http://www.cochranelibrary.com: 96 p.

32. Anzueto A.R., Schaberg T. Acute exacerbations of chronic bronchitis. Clinician's manual. Current Medicine Group Ltd, 2006: 70 p.

33. Poole P, Chong J, Cates CJ. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease (Review). Cochrane Database of Systematic Reviews 2015, Issue 7. http://www.cochranelibrary.com: 101 p.

34. Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings (Review). Cochrane Database of Systematic Reviews 2014, Issue 11. http://www.cochranelibrary.com: 53 p.

35. Чучалин А.Г., Сахарова Г.М., Новиков К.Ю. Руководство по лечению табачной зависимости. Русский медицинский журнал, 2001, том 9, N 21 (140): с. 904 - 912.

36. Новиков К.Ю., Сахарова Г.М., Чучалин А.Г. Респираторный статус у больных хроническим бронхитом во время отказа от табакокурения. Пульмонология 2002, 4: 78 - 81.

37. Чучалин А.Г., Антонов Н.С., Сахарова Г.М., Андреева С.А. Гиперреактивность бронхов у курящих людей и ее коррекция с помощью Форадила во время отказа от курения. Пульмонология, 2006, N 5: с. 49 - 55.

38. Global Initiative for Chronic Lung Disease (GOLD) (2018 Report). http://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf

39. Tee A, Koh M S, Gibson G, Lasserson T J, Wilson A, Irving L B Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma. Cochrane Database of Systematic Reviews, 2007, http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001281.pub2/ful

40. Sestini P, Renzoni E, Robinson S, Poole Ph, Ram F SF. Short-acting beta2-agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2002, http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001495/full

41. Appleton S, Poole Ph, Smith B J, Veale A, Lasserson T J, Ki Chan M M, Cates C J. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2006, http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001104.pub2/full

42. Wedzicha JA, Banerji D, Chapman KR et al.; FLAME Investigators. Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD//N Engl J Med. 2016; 374 (23): 2222 - 34.

43. Vincken W, Aumann J, Chen H et al. Efficacy and safety of coadministration of oncedaily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study. Int J Chron Obstruct Pulmon Dis 2014; 9: 215 - 28.

44. Wedzicha JA, Dahl R, Buhl R et al. Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients. Respir Med 2014; 108: 1498 - 507.

45. Ulrik CS. Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once a daily in patients with chronic obstructive pulmonary disease: a systematic review. Int J Chron Obstruct Pulmon Dis 2014; 9: 331 - 8.

46. Buhl R., Maltais F., Abrahams R. et al. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2 - 4)//Eur Respir J, 2015; 45: 969 - 979.

47. Сахарова Г.М., Антонов Н.С. Оказание помощи по отказу от табака в терапевтической практике. М.: УП Принт, 2010: 64 с.

48. Bissell K., Fraser T., Chen-Yuan Ch., Enarson D.A. Smoking cessation and smokefree environments for tuberculosis patients. International Union Against Tuberculosis and Lung Disease, 2010: 50 p.

49. Бек Д.С. Когнитивная терапия: полное руководство: Пер. с англ. - М.: ООО "И.Д. Вильямс", 2006: 400 с.

50. Сахарова Г.М., Антонов Н.С. Табакокурение и репродуктивная функция женщин. РМЖ. Акушерство и гинекология, 2013, N 1: с. 12 - 20

51. Coleman, T., Chamberlain C., Davey M.-A., Cooper S. E., Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews 2012, http://www.cochranelibrary.com